WallStreetZenWallStreetZen

NASDAQ: PHAT
Phathom Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Phathom Pharmaceuticals earnings were -$334.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PHAT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$74.5M, down 13% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PHAT reported annual earnings of -$334.3M, with 65.8% growth. The next PHAT earnings date is May 7, 2025.

PHAT earnings history

Current Revenue
$55.3M
Current Earnings
-$334.3M
Current Profit Margin
-605.1%

PHAT Return on Equity

Current Company
N/A
Current Industry
-2%
Current Market
34.1%

PHAT undefined

Current Company
-92.8%
Current Industry
-0.4%
PHAT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PHAT announces earnings.

PHAT undefined

Current Company
-89.65%
Current Industry
5.9%
PHAT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PHAT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PHAT-$261.52M-$334.33MN/A-$5.29
ATAI-$145.61M-$149.27MN/A-$0.93
GLUE-$62.01M-$72.70MN/A-$0.98
AURA-$84.11M-$86.92MN/A-$1.75
ATXS-$94.26M-$94.26MN/A-$1.68
View Top Biotech Stocks

PHAT earnings dates

Next earnings date
May 7, 2025

Phathom Pharmaceuticals Earnings Reports & History FAQ

What were Phathom Pharmaceuticals's earnings last quarter?

On PHAT's earnings call on Invalid Date, Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 2024 earnings per share (EPS) of -$1.00, up 31.03% year over year. Total PHAT earnings for the quarter were -$74.45 million. In the same quarter last year, Phathom Pharmaceuticals's earnings per share (EPS) was -$1.45.

If you're new to stock investing, here's how to buy Phathom Pharmaceuticals stock.

When does Phathom Pharmaceuticals report earnings?

The next PHAT earnings call is Invalid Date. Add PHAT to your watchlist to be reminded of Phathom Pharmaceuticals's next earnings date.

What was PHAT's earnings growth in the past year?

As of Phathom Pharmaceuticals's earnings date in Invalid Date, Phathom Pharmaceuticals's earnings has grown year over year. PHAT earnings in the past year totalled -$334.33 million.

Is Phathom Pharmaceuticals profitable or losing money?

As of the last Phathom Pharmaceuticals earnings report, Phathom Pharmaceuticals is currently losing money. Phathom Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$334.33 million, a 65.84% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.